Rheumatology Patient Registry and Biorepository

Study Overview
=================
Brief Summary
-----------------
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Detailed Description
-----------------
A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients seen at Yale clinics diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease.

Official Title
-----------------
Rheumatology Patient Registry and Biorepository

Conditions
-----------------
Psoriatic Arthritis, Rheumatic Diseases, Adult Onset Still Disease, Ankylosing Spondylitis, Reactive Arthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Behcet Disease, Dermatomyositis, Polymyositis, Giant Cell Arteritis, Lyme Disease, Mixed Connective Tissue Disease, Polymyalgia Rheumatica, Rheumatoid Arthritis, Sarcoidosis, Systemic Sclerosis, Scleroderma, Sjogren's Syndrome, Undifferentiated Connective Tissue Diseases

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria for Rheumatology Patients: Patients ≥18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis. Receiving clinical care at Yale Rheumatology clinics Exclusion Criteria for Rheumatology Patients: Unable to provide informed consent No patients will be excluded based on gender or ethnicity or pregnancy status. Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver. Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy. Inclusion Criteria for Healthy Volunteers: Age ≥ 18 years old No chronic skin conditions No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis) Normal BMI Exclusion Criteria for Healthy Volunteers: Unable to provide informed consent. Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman. Allergies to lidocaine or epinephrine (skin biopsies). A history of impaired wound healing (skin biopsies).

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Biorepository<br>Participants with rheumatic diseases who contributed biospecimen samples (blood, saliva, urine, stool, tissue). | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Correlate outcomes and biomarkers of rheumatic diseases | Evaluate clinical data and biospecimens to correlate outcomes and biomarkers of rheumatic diseases. | 10 years |